Related Experiment Video
Updated: Mar 15, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Multiple Endocrine Neoplasia: A Genetically Diverse Group of Familial Tumor Syndromes
1Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee.
Abstract:
Multiple endocrine neoplasia (MEN) syndrome is a familial cancer syndrome characterized by neuroendocrine tumors. The syndrome encompasses four major subtypes: MEN1, MEN2A, MEN2B, and MEN4. MEN1 is caused by mutations in the MEN1 gene, MEN2A and MEN2B are caused by mutations in RET, and MEN4 is caused by mutations in CDKNB1. All are inherited in an autosomal dominant pattern, but de novo cases do arise. While all subtypes are associated with neuroendocrine tumors, each has characteristic organ involvement. Identifying patients with the syndrome can aid in proper screening and treatment.
Insights
Multiple endocrine neoplasia (MEN) is an inherited cancer syndrome featuring neuroendocrine tumors. Understanding its four subtypes (MEN1, MEN2A, MEN2B, MEN4) and genetic causes aids in diagnosis and management.
Area of Science:
- Genetics
- Oncology
- Endocrinology
Background:
- Multiple endocrine neoplasia (MEN) syndromes are inherited disorders.
- Characterized by the development of neuroendocrine tumors.
- Encompasses four main subtypes: MEN1, MEN2A, MEN2B, and MEN4.
Purpose of the Study:
- To outline the genetic basis of MEN subtypes.
- To describe the characteristic organ involvement for each subtype.
- To emphasize the importance of identifying MEN for screening and treatment.
Main Methods:
- Review of genetic mutations associated with MEN subtypes.
- Analysis of clinical presentations and organ specificity.
- Discussion of inheritance patterns (autosomal dominant, de novo).
Main Results:
- MEN1 is linked to MEN1 gene mutations.
- MEN2A and MEN2B are linked to RET gene mutations.
- MEN4 is linked to CDKNB1 gene mutations.
- All subtypes involve neuroendocrine tumors but differ in affected organs.
Conclusions:
- Accurate identification of MEN subtypes is crucial.
- Genetic diagnosis informs targeted screening protocols.
- Early detection improves patient management and outcomes.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Endocrine Signaling
Endocrine Signaling
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
What is the Endocrine System?
Mitogens and the Cell Cycle
